Work

Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma

Year: 2022

Type: article

Abstract: Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma

Source: Haematologica

DOI: 10.3324/haematol.2021.280464

Authors: Cyril Quivoron, Anthony Tarabay, Jean-Marie Michot, Arnaud Pagès, Hélène Lecourt, Anne Aupérin, Alina Danu, Julien Lazarovici, Julien Rossignol, David Ghez, Peggy Dartigues, Véronique Vergé, Christophe Massard, Valérie Camara-Clayette, Vincent Ribrag, Clémentine Sarkozy

Institutions: Centre National de la Recherche Scientifique, Inserm, Institut Gustave Roussy, Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse, Fondation Gustave Roussy

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

OpenAlex ID: W4220927765

FWCI: 0.333

Cites: 11

Cited by: 2

Related to: 10